Selected Publications
- Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?. Aaron E. Miller. Multiple Sclerosis Journal
- Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial. John R. Corboy, Robert J. Fox, Ilya Kister, Gary R. Cutter, Charity J. Morgan, Rebecca Seale, Eric Engebretson, Tarah Gustafson, Aaron E. Miller, Dennis Bourdette, Vijayshree Yadav, Andrew Goodman, Michael Racke, Robert Fallis, Carlo Tornatore, Myla Goldman, Meena Kannan, Subramaniam Sriram, Joseph Berger, Anne Cross, Kottil Rammohan, Zongqi Xia, Thomas Leist, Sharon Lynch, Eric Klawiter, Lilyana Amezcua, James Bowen. The Lancet Neurology
- Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy. Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, Kevin Tuballes, Juan Manuel Carreño, Sammita Satyanarayan, Susan Filomena, Erin Staker, Johnstone Tcheou, Aaron Miller, Michelle Fabian, Neha Safi, Jamie Nichols, Jasmin Patel, Stephen Krieger, Stephanie Tankou, Sam Horng, Sylvia Klineova, Erin Beck, Miriam Merad, Fred Lublin. Multiple Sclerosis and Related Disorders